Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Electrical Impedance Myography Detects Disease Progression over 12 to 24 Months in Facioscapulohumeral Muscular Dystrophy.
Journal: Annals of neurology
Published: November 14, 2025
Targeted Therapeutics for Transthyretin Amyloid Cardiomyopathy.
Journal: American journal of therapeutics
Published: September 15, 2023
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial.
Journal: The Lancet. Neurology
Published: July 19, 2023
Lean tissue mass measurements by dual-energy X-ray absorptiometry and associations with strength and functional outcome measures in facioscapulohumeral muscular dystrophy.
Journal: Neuromuscular disorders : NMD
Published: May 08, 2023
Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy.
Journal: Frontiers in cardiovascular medicine
Published: March 29, 2022
Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Journal: Cardiology and therapy
Published: March 10, 2022
Infections of the Peripheral Nervous System.
Journal: Continuum (Minneapolis, Minn.)
Published: October 08, 2021
Factors Influencing the Severity and Progression of Respiratory Muscle Dysfunction in Myotonic Dystrophy Type 1.
Journal: Frontiers in neurology
Published: January 25, 2021
Marked reduction in paralytic attacks in a patient with Andersen-Tawil syndrome switched from acetazolamide to dichlorphenamide.
Journal: Neuromuscular disorders : NMD
Published: January 12, 2021
A Roadmap to Patient Engagement: Facioscapulohumeral Muscular Dystrophy and the ReSolve Clinical Trial.
Journal: Neurology. Clinical practice
Published: November 13, 2020
Last Updated: 09/26/2026